LCM
OFIX icon

Legato Capital Management’s Orthofix Medical OFIX Stock Holding History

Legato Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,736
Closed -$730K – 608
2023
Q3 		$730K Sell
56,736
-2,705
-5% -$48.7K 0.11% 312
2023
Q2 		$1.07M Buy
59,441
+24,925
+72% +$466K 0.15% 241
2023
Q1 		$578K Buy
+34,516
New +$675K 0.11% 329

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legato Capital Management's OFIX Position: Q4 2023 in Review

Legato Capital Management sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 56,736 shares — an estimated $730K sold.

Legato Capital Management first reported a position in OFIX in Q1 2023 and held it in 3 quarters. The position peaked at $1.07M in Q2 2023. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • Legato Capital Management reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • Legato Capital Management sold 56,736 Orthofix Medical shares in Q4 2023, an estimated $730K.
  • Legato Capital Management first reported a position in Orthofix Medical in Q1 2023 and held it in 3 quarters.
  • Legato Capital Management's Orthofix Medical position peaked at $1.07M in Q2 2023.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on Legato Capital Management's 13F filing for Q4 2023, filed 16 Jan 2024.